Company: EHC
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000785161-25-000009
Chunk: 184

Company: Encompass Health Corp
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 184
---
Purchases of restricted investments(22.5)(23.0)(35.2)Other, net(7.2)(4.1)(4.2)Net cash used in investing activities of discontinued operations— — (3.5)Net cash used in investing activities(653.3)(602.8)(627.0)

(Continued)F-8

Encompass Health Corporation and SubsidiariesConsolidated Statements of Cash Flows (Continued)

 For the Year Ended December 31, 202420232022 (In Millions)Cash flows from financing activities:   Principal payments on debt, including pre-payments(255.2)(7.2)(345.8)Principal borrowings on notes15.0 20.0 11.8 Borrowings on revolving credit facility80.0 60.0 240.0 Payments on revolving credit facility(60.0)(115.0)(385.0)Principal payments under finance lease obligations(21.8)(41.1)(19.2)Debt amendment and issuance costs(0.1)(0.1)(24.1)Repurchases of common stock, including fees and expenses(31.1)— — Dividends paid on common stock(62.8)(60.4)(99.0)Distributions paid to noncontrolling interests of consolidated affiliates(125.0)(114.7)(96.6)Taxes paid on behalf of employees for shares withheld(12.1)(8.2)(7.3)Contributions from noncontrolling interests of consolidated affiliates140.4 68.3 64.1 Other, net2.1 1.2 0.3 Net cash provided by financing activities of discontinued operations— — 515.1 Net cash used in financing activities(330.6)(197.2)(145.7)Increase (decrease) in cash, cash equivalents, and restricted cash18.9 50.8 (66.9)Cash, cash equivalents, and restricted cash at beginning of year104.2 53.4 120.3 Cash, cash equivalents, and restricted cash at end of year$123.1 $104.2 $53.4 Reconciliation of Cash, Cash Equivalents, and Restricted CashCash and cash equivalents at beginning of period$69.1 $21.8 $49.4